Skip to content

H.R. 71 · 118th Congress (2023–2025)

Medical Innovation Acceleration Act of 2023

This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.

The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is H.R. 71’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Andy Biggs (R-AZ-5)
Policy area
Health
Subjects
  • Administrative remedies
  • Drug safety, medical device, and laboratory regulation
  • Food and Drug Administration (FDA)

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Referred to Health

    Referred to the Subcommittee on Health.

    Sources
  2. Introduced in House

    Document: Introduced in House

    Sources
  3. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources
  4. Expired

    Introduced → Referred to House Energy and Commerce → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jan 9, 2023
  2. HouseHealthReferred Jan 9, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Medical Innovation Acceleration Act of 2023

    Display title, Short title · Introduced in House

  2. To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.

    Official title · Introduced in House